Global DSI Negotiations Highlight Colonial Biopiracy: South Africa Advocates for Equitable Benefit-Sharing Frameworks
Original framing: “SA Calls for Global Equity in Biodiversity Benefits as DSI Talks Advance” — bing news
The original framing omits the historical context of biopiracy, such as the 1992 Rio Convention on Biological Diversity's failure to address colonial-era theft or the ongoing exploitation of indigenous knowledge without consent. It also ignores the role of Northern pharmaceutical and agribusiness corporations in patenting genetic resources from the Global South, as well as the lack of representation of indigenous communities and local farmers in ABS negotiations. Additionally, the framing overlooks the structural power imbalances in the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO), which prioritize corporate interests over equitable access.
High structural omission detected in mainstream coverage.
The narrative is produced by Western-centric news outlets and policy think tanks, often funded by or aligned with Northern academic and corporate interests, which benefit from the status quo of uncompensated resource extraction. The framing serves to legitimize the current system by presenting ABS as a voluntary best practice rather than a necessary corrective to historical injustices. It obscures the role of institutions like the WTO, WIPO, and CBD in perpetuating these imbalances, while centering South Africa's compliance with global norms over its leadership in challenging systemic inequities.
Scenario modeling suggests that without radical reform, 75% of global biodiversity could be lost by 2050, with the Global South bearing the brunt of ecosystem collapse due to uncompensated exploitation. Alternative futures, such as the 'One Health' approach integrating indigenous knowledge with modern science, could mitigate these losses but require dismantling corporate monopolies on genetic resources. The rise of 'bioeconomy' initiatives in the Global South—such as Brazil's 'Amazonian Bioeconomy Plan'—offers a pathway to rebalance power but faces resistance from Northern interests.
The call for global equity in biodiversity benefits is not merely a policy debate but a confrontation with the colonial legacies of biopiracy, where Northern corporations and institutions have extracted trillions in value from the Global South without compensation.